Collectively, these data indicate the enhanced proliferation and invasion of cancers including lung cancer, OVCA, HCC, PTC, and GBM are positively related to increased USP13 levels or USP13 mutation and genetic or pharmacological inhibition of USP13 exhibits notable suppression of tumor growth and invasion. This evidence concerns the gene USP13 and glioblastoma.